Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial by Stroke Subtypes
Stroke 40:1405-1409, Amarenco,P.,et al, 2009
Statin Treatment and the Occurrence of Hemorrhagic Stroke in Patients With a History of Cerebrovascular Disease
Stroke 39:497-502, Vergouwen,M.D.I.,et al, 2008
Progress in Secondary Stroke Prevention
Ann Neurol 63:418-427, Romano,J.G. &Sacco,R.L., 2008
Prognostic Importance of Leukoaraiosis in Patients with Symptomatic Internal Carotid Artery Stenosis
Stroke 33:1651-1655, Streifler,J.Y.,et al, 2002
New Evidence for Stroke Prevention
JAMA 288:1388-1395, Straus,S.E.,et al, 2002
Primary Prevention of Ischemic Stroke
Stroke 32:280-299, Goldstein,L.B.,et al, 2001
Is Cholesterol a Risk Factor for Stroke? No
Arch Neurol 56:1521-1524, Landau,W.M., 1999
Is Cholesterol a Risk Factor for Stroke? Yes
Arch Neurol 56:1518-1520,1524, Demchuk,A.M.,et al, 1999
Effect of HMGcoA Reductase Inhibitors on Stroke, A Meta-Analysis of Controlled Trials
Ann Int Med 128:89-95, Bucher,H.C.,et al, 1998
Predictors of Stroke in Middle-Aged Patients with Non-Insulin-Dependent Diabetes
Stroke 27:63-68, Lehto,S.,et al, 1996
Lipids and Stroke
Arch Neurol 53:303-308, Hachinski,V.,et al, 1996
Failure of Aspirin Treatment After Stroke
Stroke 25:275-277, Bornstein,N.M.,et al, 1994
Ticlopidine for Prevention of Stroke
The Medical Letter, 34:65-661992., , 1992
Familial Hyperlipidemia in Stroke in the Young
Stroke 17:1142-1145, Bansal,B.C.,et al, 1986